Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES NATCO PHARMA ZYDUS LIFESCIENCES/
NATCO PHARMA
 
P/E (TTM) x 20.1 25.4 79.2% View Chart
P/BV x 2.4 2.4 98.5% View Chart
Dividend Yield % 0.6 0.8 78.4%  

Financials

 ZYDUS LIFESCIENCES   NATCO PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
NATCO PHARMA
Mar-22
ZYDUS LIFESCIENCES/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs6741,189 56.7%   
Low Rs331750 44.1%   
Sales per share (Unadj.) Rs149.1106.6 139.9%  
Earnings per share (Unadj.) Rs22.79.3 244.0%  
Cash flow per share (Unadj.) Rs29.717.1 173.3%  
Dividends per share (Unadj.) Rs2.504.50 55.6%  
Avg Dividend yield %0.50.5 107.2%  
Book value per share (Unadj.) Rs166.1233.4 71.1%  
Shares outstanding (eoy) m1,023.74182.52 560.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.49.1 37.0%   
Avg P/E ratio x22.1104.1 21.2%  
P/CF ratio (eoy) x16.956.6 29.9%  
Price / Book Value ratio x3.04.2 72.8%  
Dividend payout %11.048.3 22.8%   
Avg Mkt Cap Rs m514,277176,990 290.6%   
No. of employees `000NANA-   
Total wages/salary Rs m21,7774,448 489.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,65219,448 784.9%  
Other income Rs m2,354990 237.8%   
Total revenues Rs m155,00620,438 758.4%   
Gross profit Rs m34,4272,635 1,306.5%  
Depreciation Rs m7,1301,426 500.0%   
Interest Rs m1,270177 717.5%   
Profit before tax Rs m28,3812,022 1,403.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,117322 1,589.1%   
Profit after tax Rs m23,2641,700 1,368.5%  
Gross profit margin %22.613.5 166.5%  
Effective tax rate %18.015.9 113.2%   
Net profit margin %15.28.7 174.3%  
BALANCE SHEET DATA
Current assets Rs m122,61424,972 491.0%   
Current liabilities Rs m78,3947,104 1,103.5%   
Net working cap to sales %29.091.9 31.5%  
Current ratio x1.63.5 44.5%  
Inventory Days Days9370 132.0%  
Debtors Days Days80116 68.6%  
Net fixed assets Rs m144,38226,119 552.8%   
Share capital Rs m1,024365 280.5%   
"Free" reserves Rs m168,97242,237 400.1%   
Net worth Rs m169,99642,602 399.0%   
Long term debt Rs m3,6210-   
Total assets Rs m266,99651,091 522.6%  
Interest coverage x23.312.4 187.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.4 150.2%   
Return on assets %9.23.7 250.1%  
Return on equity %13.74.0 342.9%  
Return on capital %17.15.2 330.9%  
Exports to sales %00-   
Imports to sales %14.320.0 71.8%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m21,8693,882 563.3%   
Fx inflow Rs m63,0658,881 710.1%   
Fx outflow Rs m21,8693,882 563.3%   
Net fx Rs m41,1964,999 824.1%   
CASH FLOW
From Operations Rs m21,041465 4,524.9%  
From Investments Rs m11,544-53 -21,781.1%  
From Financial Activity Rs m-8,683348 -2,495.1%  
Net Cashflow Rs m23,729853 2,781.8%  

Share Holding

Indian Promoters % 75.0 48.8 153.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.5 26.0 59.8%  
FIIs % 2.6 11.7 22.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 51.2 48.9%  
Shareholders   408,231 121,336 336.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    DR. REDDYS LAB    LUPIN    CIPLA    AUROBINDO PHARMA    


More on Cadila Healthcare vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Natco Pharma Share Price Performance

Period Cadila Healthcare Natco Pharma S&P BSE HEALTHCARE
1-Day 2.28% -0.20% 0.33%
1-Month -3.70% -4.74% 0.28%
1-Year -13.04% -31.33% -6.55%
3-Year CAGR 16.15% -0.19% 20.31%
5-Year CAGR -1.98% -9.46% 10.96%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Natco Pharma the stake stands at 48.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

Natco Pharma paid Rs 4.5, and its dividend payout ratio stood at 48.3%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 21 Points Higher | BHEL, RVNL Surge 10% to Hit 52-Week High | Why PNB Share Price is Rising(Closing)

Indian share markets traded in a rangebound manner throughout today's session to end flat.